Comments*

 
  • Academy Events

  • Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Tuesday, June 21, 2016 | 8:30 AM - 5:00 PM
    The New York Academy of Sciences

    Presented by The Alzheimer's Drug Discovery Foundation and the Brain Dysfunction Discussion Group

    Related Content

    Surgery helps millions of Americans overcome illness to live longer, healthier lives. Yet for many of these people, surgery can lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia. These risks are poorly understood and often under-recognized in the clinic. The level of risk to a patient depends on the individual and the surgery. For example, delirium is experienced in 15–80% of surgical patients who, in turn, may have a higher risk of long-term cognitive and functional decline. This one-day meeting will convene leading scientists to discuss the challenges and opportunities to create biomarkers and therapeutics for these vulnerable patients.

    Registration Pricing

    Member $60
    Member (Student / Postdoc / Resident / Fellow) $25
    Nonmember (Academia) $105
    Nonmember (Corporate) $160
    Nonmember (Non-profit) $105
    Nonmember (Student / Postdoc / Resident / Fellow) $70

    This event will also be broadcast as a webinar; registration is required.

    Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.

    Webinar Pricing

    Member $30
    Member (Student / Postdoc / Resident / Fellow) $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Resident / Fellow) $45


    Presented by

    • Alzheimer's Drug Discovery Foundation
    • The New York Academy of Sciences

    The Brain Dysfunction Discussion Group is proudly supported by


    • Acorda Therapeutics
    EmailPrint